## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 3.8% below STRENGTH zone (4.0-10.0%); PEG 2.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($150.06)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Why Lam Research (LRCX) Stock Is Up Today**
- Source: Finviz | 20251208T171515 | Bullish | Relevance: 98%
-  Shares of Lam Research (LRCX) rose after Morgan Stanley increased its price target for the semiconductor equipment maker, citing a 13% increase in its 2027 Wafer Fab Equipment market forecast. The stock's gain aligns with a broader positive trend in the chip-making sector. Lam Research has seen significant growth year-to-date, trading near its 52-week high.

**2. SVB Wealth LLC Acquires Shares of 28,255 Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T124742 | Somewhat-Bullish | Relevance: 98%
-  SVB Wealth LLC has acquired 28,255 shares of Lam Research Corporation, valued at approximately $2.75 million, establishing a new position in the semiconductor company. This comes as other institutional investors have also adjusted their holdings, with institutional ownership now standing at around 84.61%. Despite recent insider selling, Lam Research reported a strong quarterly performance, exceeding EPS and revenue expectations, and analysts currently rate the stock as a "Moderate Buy" with an average target price of $152.87.

**3. Lam Research Corporation $LRCX Position Decreased by Four Tree Island Advisory LLC**
- Source: MarketBeat | 20251206T080900 | Somewhat-Bullish | Relevance: 98%
-  Four Tree Island Advisory LLC decreased its holdings in Lam Research Corporation by 8.2% in Q2, yet it remains the firm's largest position. Despite this sale, major institutions like Vanguard and JPMorgan increased their stakes, with Norges Bank establishing a significant new position, leading to 84.61% institutional ownership. Lam Research also reported strong quarterly earnings, upbeat guidance, and declared a dividend, alongside some insider selling activities.

**4. Morgan Stanley Hikes Lam Research (LRCX) PT to $158, Keeps Equal Weight on Increased 2027 Wafer Fab Equipment Forecast**
- Source: Insider Monkey | 20251208T060836 | Somewhat-Bullish | Relevance: 98%
-  Morgan Stanley analyst Shane Brett increased the price target for Lam Research (LRCX) to $158 while maintaining an Equal Weight rating, citing an increased 2027 Wafer Fab Equipment (WFE) forecast. The company reported strong Q1 2026 revenues of $5.32 billion and provided optimistic guidance for Q2 2026, projecting ~$5.2 billion revenues. Despite the positive outlook, the article suggests that other AI stocks might offer greater return potential.

**5. Investment Management Corp of Ontario Increases Stock Position in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T141418 | Somewhat-Bullish | Relevance: 98%
-  Investment Management Corp of Ontario significantly increased its stake in Lam Research Corporation by 90.3% in the second quarter, now owning 108,638 shares valued at $10.575 million. Other institutional investors also adjusted their positions in the semiconductor company. Insider activity and analyst ratings are also detailed, with analysts giving Lam Research an average rating of "Moderate Buy" and a consensus target price of $152.87.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $14M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +2.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.39 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $205.2B |
| Beta | 1.78 |
| 52W Range | $56.32 - $167.15 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.39 |
| Forward P/E | 29.1 |
| Current P/E | 33.7 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.9% to 3.8% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. AM_20 at 5.9% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.70), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.80% (CS: 80) | Neutral |
| RSI_14 | 60.2 | Neutral |
| MACD Histogram | 0.70 | Bullish |
| vs SMA20 | 1.058x | Above |
| vs SMA50 | 1.084x | Above |
| vs SMA200 | 1.554x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $162.74
- **Stop Loss:** $150.06 (7.8% risk)
- **Target:** $175.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 94
- **Position Value:** $15,297.56
- **Portfolio %:** 15.30%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*